PTPN4 germline variants result in aberrant neurodevelopment and growth - Sorbonne Université
Journal Articles Human Genetics and Genomics Advances Year : 2021

PTPN4 germline variants result in aberrant neurodevelopment and growth

PTPN4 germline variants result in aberrant neurodevelopment and growth.

Abstract

Protein-tyrosine phosphatases (PTPs) are pleomorphic regulators of eukaryotic cellular responses to extracellular signals that function by modulating the phosphotyrosine of specific proteins. A handful of PTPs have been implicated in germline and somatic human disease. Using exome sequencing, we identified missense and truncating variants in PTPN4 in six unrelated individuals with varying degrees of intellectual disability or developmental delay. The variants occurred de novo in all five subjects in whom segregation analysis was possible. Recurring features include postnatal growth deficiency or excess, seizures, and, less commonly, structural CNS, heart, or skeletal anomalies. PTPN4 is a widely expressed protein tyrosine phosphatase that regulates neuronal cell homeostasis by protecting neurons against apoptosis. We suggest that pathogenic variants in PTPN4 confer risk for growth and cognitive abnormalities in humans.
Fichier principal
Vignette du fichier
mmc3.pdf (3.06 Mo) Télécharger le fichier
Origin Publication funded by an institution
Licence

Dates and versions

hal-04536949 , version 1 (08-04-2024)

Licence

Identifiers

Cite

Joanna J Chmielewska, Deepika Burkardt, Jorge Luis Granadillo, Rachel Slaugh, Shamile Morgan, et al.. PTPN4 germline variants result in aberrant neurodevelopment and growth. Human Genetics and Genomics Advances, 2021, 2 (3), pp.100033. ⟨10.1016/j.xhgg.2021.100033⟩. ⟨hal-04536949⟩
15 View
5 Download

Altmetric

Share

More